Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |